Evidence map›Paper›PMID 34779492›Full record

ArticleInternational journal of molecular medicine2022

The DR1‑CSE/H

Hongzhu Li, Fengqi Sun, Shuzhi Bai, Guiquan Chang, Ren Wu, Yaxin Wei, Xin Wen, Yuxin Xi, Jinghui Hao, Altaany Zaid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Dopamine receptors and organ fibrosis.Biochemistry and biophysics reports · 2025
    Review
  4. Age-dependent effects of HFrontiers in psychiatry · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hongzhu Li *Department of Pathophysiology, School of Medicine, Xiamen University, Xiamen, Fujian 361100, P.R. China.
Fengqi Sun *Department of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Shuzhi Bai *Department of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Guiquan ChangDepartment of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Ren WuDepartment of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Yaxin WeiDepartment of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Xin WenDepartment of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Yuxin XiDepartment of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Jinghui HaoDepartment of Pathophysiology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Altaany ZaidFaculty of Medicine, Yarmouk University, Irbid 21163, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glomerular mesangial cell (MC) proliferation and extracellular matrix deposition are the main pathological changes in diabetic nephropathy. Hydrogen sulfide (H

Indexed as

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineAnimalsCell LineCell ProliferationCollagenCystathionine gamma-LyaseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1FemaleFibrosisGlucoseHydrogen SulfideKidneyMaleMAP Kinase Signaling SystemMesangial Cells2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineCollagenCystathionine gamma-LyaseGlucoseHydrogen SulfideReceptors, Dopamine D1diabetic nephropathydopamine 1 receptorsglomerular mesangial cellshydrogen sulfideproliferation

Identifiers

PMID34779492
PMCPMC8651227

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.